Shares of Sunshine Biopharma Inc. (SBFM) are currently up over 40% following the company's announcement of a 45% revenue growth for 2024 and its positive outlook for the near future.The company filed its 2024 annual report on Form 10-K yesterday, highlighting key figures such as:• Revenue for 2024 was $34.9 million, up from $24.1 million in 2023, reflecting a 45% increase.• The net loss widened to...
For comments and feedback contact: editorial@rttnews.com
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.